The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.

RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2.  The participants in this study are people who get tested for COVID-19 in a GGD test lane.

In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.

The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.

The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.

The number of reported COVID-19 infections continued increasing last week. However, the number of newly reported infections once again rose less quickly than in the week before that.

With the rapid increase in infections, people estimate their own risk of becoming infected as higher than it was 6 weeks ago (previously 10%, now 18%).

The number of reported cases of COVID-19 continues to rise in all regions and in all age groups. The Municipal Public Health Service (GGD) reported that 43,903 people tested positive for COVID-19 in the past week.

Two antigen tests for rapid diagnosis of COVID-19, which detect the presence of SARS-CoV-2 virus proteins within 15 minutes after testing, show very promising initial results.